- ►annals.org [PDF] W Lew, M Pai, O Oxlade, D Martin, D Menzies - Annals of Internal Medicine, 2008 - Am Coll Physicians Page 1. Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic
Review and Meta-analysis Woojin Lew, MD, MSc; Madhukar ... Cited by 9 - Related articles - All 8 versions
JE Oeltmann, JK Varma, L Ortega, Y Liu, TO' … - Emerging Infectious Diseases, 2008 - pubmedcentral.nih.gov In January 2005, tuberculosis (TB), including multidrug-resistant TB (MDR TB),
was reported among Hmong refugees who were living in or had recently immigrated
to the United States from a camp in Thailand. We investigated TB and drug ... Cited by 5 - Related articles - All 9 versions
- ►atsjournals.org A Mak, A Thomas, M del Granado, R Zaleskis … - American Journal of Respiratory and Critical Care …, 2008 - Am Thoracic Soc Measurements and Main Results: Among countries using one of two standardized
initial regimens, failure rates averaged 5.0%, and relapse rates averaged 12.8%
in the 20 countries where prevalence of initial multidrug resistance ... Cited by 18 - Related articles - All 5 versions
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
S Ahmad, E Mokaddas - Respiratory Medicine, 2009 - Elsevier Tuberculosis (TB) is a major infectious disease killing nearly two million
people, mostly in developing countries, every year. The increasing incidence of
resistance of Mycobacterium tuberculosis strains to the most-effective ... Related articles - All 2 versions
[CITATION] Last literature review version 16.3: Wed Oct 01 00: 00: 00 GMT 2008| This topic last …
GH Bothamley - Expert Review of Obstretrics and Gynecology, 2009 - ingentaconnect.com Tuberculosis is thought to be present in a latent form in approximately a third
of the world's pop- ulation [1]. The WHOestimated that, in 2007, there were 9.27
million cases of active TB, an incidence of 139 per 100,000 people [2]. In ... Related articles - All 3 versions
I Inductivo-Yu, M Bonacini - Current drug safety, 2008 - ncbi.nlm.nih.gov With the advent of highly active antiretroviral therapy (HAART), the reduction
in overall mortality and morbidity in HIV patients has been accompanied by the
emergence of liver disease as a leading cause of death. Elevated liver ... Cited by 1 - Related articles
S Basu, E Orenstein, AP Galvani - The Journal of Infectious Diseases, 2008 - UChicago Press Featured in New Scientist "Are we about to eliminate AIDS?" February 19, 2009
Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and
in Those Not Receiving ART at Baseline in the SMART Study The Strategies ... Cited by 1 - Related articles - All 4 versions
